5oe5
From Proteopedia
(Difference between revisions)
												
			
			|  (New page:  ==Crystal structure of the N-terminal domain of PqsA in complex with anthraniloyl-AMP (crystal form 3)== <StructureSection load='5oe5' size='340' side='right' caption='5oe5, [[Resolut...) | |||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| ==Crystal structure of the N-terminal domain of PqsA in complex with anthraniloyl-AMP (crystal form 3)== | ==Crystal structure of the N-terminal domain of PqsA in complex with anthraniloyl-AMP (crystal form 3)== | ||
| - | <StructureSection load='5oe5' size='340' side='right' caption='[[5oe5]], [[Resolution|resolution]] 1.74Å' scene=''> | + | <StructureSection load='5oe5' size='340' side='right'caption='[[5oe5]], [[Resolution|resolution]] 1.74Å' scene=''> | 
| == Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5oe5]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OE5 OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5oe5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Pseudomonas_aeruginosa_PAO1 Pseudomonas aeruginosa PAO1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OE5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5OE5 FirstGlance]. <br> | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3UK:5-O-[(S)-[(2-AMINOBENZOYL)OXY](HYDROXY)PHOSPHORYL]ADENOSINE'>3UK</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.74Å</td></tr> | 
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3UK:5-O-[(S)-[(2-AMINOBENZOYL)OXY](HYDROXY)PHOSPHORYL]ADENOSINE'>3UK</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5oe5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5oe5 OCA], [https://pdbe.org/5oe5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5oe5 RCSB], [https://www.ebi.ac.uk/pdbsum/5oe5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5oe5 ProSAT]</span></td></tr> | 
| </table> | </table> | ||
| == Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/PQSA_PSEAE PQSA_PSEAE] Catalyzes the formation of anthraniloyl-CoA, which is the priming step for entry into the Pseudomonas quinolone signal (PQS) biosynthetic pathway. Also active on a variety of aromatic substrates, including benzoate and chloro and fluoro derivatives of anthranilate.<ref>PMID:18083812</ref> <ref>PMID:18728009</ref>  | 
| <div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| == Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 23: | ||
| __TOC__ | __TOC__ | ||
| </StructureSection> | </StructureSection> | ||
| - | [[Category:  | + | [[Category: Large Structures]] | 
| - | [[Category:  | + | [[Category: Pseudomonas aeruginosa PAO1]] | 
| - | [[Category:  | + | [[Category: Blankenfeldt W]] | 
| - | [[Category:  | + | [[Category: Ewert W]] | 
| - | [[Category:  | + | [[Category: Witzgall F]] | 
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Crystal structure of the N-terminal domain of PqsA in complex with anthraniloyl-AMP (crystal form 3)
| 
 | |||||||||||
